NASDAQ
Aardvark Therapeutics, Inc. Common Stock (AARD) has a free cash flow growth of -30.83% as of Friday, May 29, 2026. This represents a 24.80% decrease compared to its 12-month average of -24.70%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.